NMPA Issued the Notice on the Implementation Plan of the State Council for Full-Coverage Pilot Reform of Separated Management of Permit and License in the Free Trade Pilot Areas
NMPA issued a corresponding pilot implementation plan covering five parts:the guiding ideology, the scope and content of the pilot, the classified promotion of the reform of the examination and approval system,the improvement of the supporting measures for reform, and the effectiveimplementation of the reform policy.
NMPA and NHC Jointly Issued the Announcement on Regulations for the Administration of Drug Clinical Trial Institutions
NMPA has formulated,in conjunction with the National Health and Health Commission (NHC), the Regulations for the Administration of Drug Clinical Trial Institutions, which has been released on November 29, 2019, and shall take effect as from December 1, 2019.
NMPA Issued the Announcement on Enabling the New Version of Management System for Import Filing of Drugs and Medicinal Materials
NMPA and the General Administration of Customs have collaboratively established a management system for import filing of pharmaceuticals and medicinal material imports.
NMPA issued the Notice on Enabling the Import and Export Permit Management System, which clearly states that the drug import and export permit management system has been officially launched since December 25, 2019.
NMPA has integrated the development of a drug business application system to this end,covering the certificates for drug export sales,APIs exporting to EU drug substance,import and export of narcotic drugs and psychotropic substances,and the initial import of medicinal materials,etc.
On January 3, 2020, Premier Li Keqiang presided over an executive meeting of the State Council. In the meeting, the Regulation for Supervision of Cosmetics (Draft) was approved.